292 related articles for article (PubMed ID: 18573260)
1. Myosin binding protein C phosphorylation in normal, hypertrophic and failing human heart muscle.
Jacques AM; Copeland O; Messer AE; Gallon CE; King K; McKenna WJ; Tsang VT; Marston SB
J Mol Cell Cardiol; 2008 Aug; 45(2):209-16. PubMed ID: 18573260
[TBL] [Abstract][Full Text] [Related]
2. Cardiac myosin-binding protein C (MyBP-C): identification of protein kinase A and protein kinase C phosphorylation sites.
Mohamed AS; Dignam JD; Schlender KK
Arch Biochem Biophys; 1998 Oct; 358(2):313-9. PubMed ID: 9784245
[TBL] [Abstract][Full Text] [Related]
3. Troponin phosphorylation and regulatory function in human heart muscle: dephosphorylation of Ser23/24 on troponin I could account for the contractile defect in end-stage heart failure.
Messer AE; Jacques AM; Marston SB
J Mol Cell Cardiol; 2007 Jan; 42(1):247-59. PubMed ID: 17081561
[TBL] [Abstract][Full Text] [Related]
4. Mutations in beta-myosin S2 that cause familial hypertrophic cardiomyopathy (FHC) abolish the interaction with the regulatory domain of myosin-binding protein-C.
Gruen M; Gautel M
J Mol Biol; 1999 Feb; 286(3):933-49. PubMed ID: 10024460
[TBL] [Abstract][Full Text] [Related]
5. Analysis of cardiac myosin binding protein-C phosphorylation in human heart muscle.
Copeland O; Sadayappan S; Messer AE; Steinen GJ; van der Velden J; Marston SB
J Mol Cell Cardiol; 2010 Dec; 49(6):1003-11. PubMed ID: 20850451
[TBL] [Abstract][Full Text] [Related]
6. MYBPC3 truncation mutations enhance actomyosin contractile mechanics in human hypertrophic cardiomyopathy.
O'Leary TS; Snyder J; Sadayappan S; Day SM; Previs MJ
J Mol Cell Cardiol; 2019 Feb; 127():165-173. PubMed ID: 30550750
[TBL] [Abstract][Full Text] [Related]
7. Organization and sequence of human cardiac myosin binding protein C gene (MYBPC3) and identification of mutations predicted to produce truncated proteins in familial hypertrophic cardiomyopathy.
Carrier L; Bonne G; Bährend E; Yu B; Richard P; Niel F; Hainque B; Cruaud C; Gary F; Labeit S; Bouhour JB; Dubourg O; Desnos M; Hagège AA; Trent RJ; Komajda M; Fiszman M; Schwartz K
Circ Res; 1997 Mar; 80(3):427-34. PubMed ID: 9048664
[TBL] [Abstract][Full Text] [Related]
8. COOH-terminal truncated cardiac myosin-binding protein C mutants resulting from familial hypertrophic cardiomyopathy mutations exhibit altered expression and/or incorporation in fetal rat cardiomyocytes.
Flavigny J; Souchet M; Sébillon P; Berrebi-Bertrand I; Hainque B; Mallet A; Bril A; Schwartz K; Carrier L
J Mol Biol; 1999 Nov; 294(2):443-56. PubMed ID: 10610770
[TBL] [Abstract][Full Text] [Related]
9. The molecular phenotype of human cardiac myosin associated with hypertrophic obstructive cardiomyopathy.
Jacques AM; Briceno N; Messer AE; Gallon CE; Jalilzadeh S; Garcia E; Kikonda-Kanda G; Goddard J; Harding SE; Watkins H; Esteban MT; Tsang VT; McKenna WJ; Marston SB
Cardiovasc Res; 2008 Aug; 79(3):481-91. PubMed ID: 18411228
[TBL] [Abstract][Full Text] [Related]
10. Uncoordinated expression of myosin heavy chains and myosin-binding protein C isoforms in human extraocular muscles.
Kjellgren D; Stål P; Larsson L; Fürst D; Pedrosa-Domellöf F
Invest Ophthalmol Vis Sci; 2006 Oct; 47(10):4188-93. PubMed ID: 17003405
[TBL] [Abstract][Full Text] [Related]
11. Phenotypic deficits in mice expressing a myosin binding protein C lacking the titin and myosin binding domains.
Yang Q; Osinska H; Klevitsky R; Robbins J
J Mol Cell Cardiol; 2001 Sep; 33(9):1649-58. PubMed ID: 11549344
[TBL] [Abstract][Full Text] [Related]
12. Effect of MyBP-C binding to actin on contractility in heart muscle.
Kulikovskaya I; McClellan G; Flavigny J; Carrier L; Winegrad S
J Gen Physiol; 2003 Dec; 122(6):761-74. PubMed ID: 14638934
[TBL] [Abstract][Full Text] [Related]
13. Titin, myosin light chains and C-protein in the developing and failing human heart.
Morano I; Hädicke K; Grom S; Koch A; Schwinger RH; Böhm M; Bartel S; Erdmann E; Krause EG
J Mol Cell Cardiol; 1994 Mar; 26(3):361-8. PubMed ID: 8028019
[TBL] [Abstract][Full Text] [Related]
14. Decreased phosphorylation levels of cardiac myosin-binding protein-C in human and experimental heart failure.
El-Armouche A; Pohlmann L; Schlossarek S; Starbatty J; Yeh YH; Nattel S; Dobrev D; Eschenhagen T; Carrier L
J Mol Cell Cardiol; 2007 Aug; 43(2):223-9. PubMed ID: 17560599
[TBL] [Abstract][Full Text] [Related]
15. Novel splice donor site mutation in the cardiac myosin-binding protein-C gene in familial hypertrophic cardiomyopathy. Characterization Of cardiac transcript and protein.
Rottbauer W; Gautel M; Zehelein J; Labeit S; Franz WM; Fischer C; Vollrath B; Mall G; Dietz R; Kübler W; Katus HA
J Clin Invest; 1997 Jul; 100(2):475-82. PubMed ID: 9218526
[TBL] [Abstract][Full Text] [Related]
16. Cardiac myosin binding protein C: its role in physiology and disease.
Flashman E; Redwood C; Moolman-Smook J; Watkins H
Circ Res; 2004 May; 94(10):1279-89. PubMed ID: 15166115
[TBL] [Abstract][Full Text] [Related]
17. Axial distribution of myosin binding protein-C is unaffected by mutations in human cardiac and skeletal muscle.
Vydyanath A; Gurnett CA; Marston S; Luther PK
J Muscle Res Cell Motil; 2012 May; 33(1):61-74. PubMed ID: 22415774
[TBL] [Abstract][Full Text] [Related]
18. Evidence from human myectomy samples that MYBPC3 mutations cause hypertrophic cardiomyopathy through haploinsufficiency.
Marston S; Copeland O; Jacques A; Livesey K; Tsang V; McKenna WJ; Jalilzadeh S; Carballo S; Redwood C; Watkins H
Circ Res; 2009 Jul; 105(3):219-22. PubMed ID: 19574547
[TBL] [Abstract][Full Text] [Related]
19. Cardiac myosin-binding protein C in the heart.
Carrier L
Arch Mal Coeur Vaiss; 2007 Mar; 100(3):238-43. PubMed ID: 17536430
[TBL] [Abstract][Full Text] [Related]
20. In vivo modeling of myosin binding protein C familial hypertrophic cardiomyopathy.
Yang Q; Sanbe A; Osinska H; Hewett TE; Klevitsky R; Robbins J
Circ Res; 1999 Oct; 85(9):841-7. PubMed ID: 10532952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
